img

Global Colorectal Cancer Diagnostics & Therapeutics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Colorectal Cancer Diagnostics & Therapeutics Market Insights, Forecast to 2034

Colorectal Cancer Diagnostics & Therapeutics refer to the tools, techniques, and treatments aimed at identifying and managing colorectal cancer, a type of cancer that originates in the colon or rectum. Diagnostics include screening methods like colonoscopy, stool tests, and imaging scans to detect the presence of cancerous growths. Therapeutics involve a range of treatments such as surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy, all tailored to the stage and characteristics of the cancer to improve patient outcomes and quality of life.
Market Analysis and InsightsGlobal Colorectal Cancer Diagnostics & Therapeutics Market
Global Colorectal Cancer Diagnostics & Therapeutics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Colorectal Cancer Diagnostics & Therapeutics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Colorectal Cancer Diagnostics & Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Colorectal Cancer Diagnostics & Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Segment by Type
Colorectal Cancer Diagnostics
Colorectal Cancer Therapeutics

Segment by Application


Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Colorectal Cancer Diagnostics & Therapeutics introduction, etc. Colorectal Cancer Diagnostics & Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Colorectal Cancer Diagnostics & Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Colorectal Cancer Diagnostics
1.2.3 Colorectal Cancer Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Perspective (2018-2033)
2.2 Global Colorectal Cancer Diagnostics & Therapeutics Growth Trends by Region
2.2.1 Colorectal Cancer Diagnostics & Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Colorectal Cancer Diagnostics & Therapeutics Market Dynamics
2.3.1 Colorectal Cancer Diagnostics & Therapeutics Industry Trends
2.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers
2.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
2.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Colorectal Cancer Diagnostics & Therapeutics by Players
3.1.1 Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Colorectal Cancer Diagnostics & Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2022
3.5 Global Key Players of Colorectal Cancer Diagnostics & Therapeutics Head office and Area Served
3.6 Global Key Players of Colorectal Cancer Diagnostics & Therapeutics, Product and Application
3.7 Global Key Players of Colorectal Cancer Diagnostics & Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2024-2033)
5 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size (2018-2033)
6.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
6.2.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
6.3.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
6.4 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
6.4.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size (2018-2033)
7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
7.2.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
7.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
7.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
7.4.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Colorectal Cancer Diagnostics & Therapeutics Market Size (2018-2033)
8.2 China Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
8.2.1 China Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023)
8.2.2 China Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033)
8.2.3 China Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
8.3 China Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
8.3.1 China Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023)
8.3.2 China Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033)
8.3.3 China Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size (2018-2033)
9.2 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
9.2.1 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
9.3 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
9.3.1 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
9.4 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Region
9.4.1 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.1.5 Biocept Recent Developments
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Details
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.2.5 Cancer Genetics Recent Developments
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.3.5 Foundation Medicine Recent Developments
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.4.5 Sysmex Corporation Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.5.5 Danaher Corporation Recent Developments
11.6 Epigenomics
11.6.1 Epigenomics Company Details
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.6.5 Epigenomics Recent Developments
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.7.5 Illumina Recent Developments
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Details
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.8.5 Rosetta Genomics Recent Developments
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Details
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.9.5 Exact Science Corporation Recent Developments
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Details
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.10.5 Pathway Genomics Corporation Recent Developments
11.11 Taiho Pharma
11.11.1 Taiho Pharma Company Details
11.11.2 Taiho Pharma Business Overview
11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Introduction
11.11.4 Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.11.5 Taiho Pharma Recent Developments
11.12 Merck KGaA
11.12.1 Merck KGaA Company Details
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Introduction
11.12.4 Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.12.5 Merck KGaA Recent Developments
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Introduction
11.13.4 Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.13.5 Amgen Recent Developments
11.14 Takeda
11.14.1 Takeda Company Details
11.14.2 Takeda Business Overview
11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Introduction
11.14.4 Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.14.5 Takeda Recent Developments
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Introduction
11.15.4 Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.15.5 Roche Recent Developments
11.16 Eli Lilly
11.16.1 Eli Lilly Company Details
11.16.2 Eli Lilly Business Overview
11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Introduction
11.16.4 Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.16.5 Eli Lilly Recent Developments
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Introduction
11.17.4 Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.17.5 Sanofi Recent Developments
11.18 Regeneron
11.18.1 Regeneron Company Details
11.18.2 Regeneron Business Overview
11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Introduction
11.18.4 Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.18.5 Regeneron Recent Developments
11.19 Bayer
11.19.1 Bayer Company Details
11.19.2 Bayer Business Overview
11.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Introduction
11.19.4 Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.19.5 Bayer Recent Developments
11.20 Onyx
11.20.1 Onyx Company Details
11.20.2 Onyx Business Overview
11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Introduction
11.20.4 Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
11.20.5 Onyx Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Colorectal Cancer Diagnostics
Table 3. Key Players of Colorectal Cancer Therapeutics
Table 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2018-2023)
Table 8. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2024-2033)
Table 10. Colorectal Cancer Diagnostics & Therapeutics Market Trends
Table 11. Colorectal Cancer Diagnostics & Therapeutics Market Drivers
Table 12. Colorectal Cancer Diagnostics & Therapeutics Market Challenges
Table 13. Colorectal Cancer Diagnostics & Therapeutics Market Restraints
Table 14. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Players (2018-2023)
Table 16. Global Top Colorectal Cancer Diagnostics & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2022)
Table 17. Global Colorectal Cancer Diagnostics & Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Colorectal Cancer Diagnostics & Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Colorectal Cancer Diagnostics & Therapeutics, Product and Application
Table 21. Global Key Players of Colorectal Cancer Diagnostics & Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Application (2018-2023)
Table 29. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Application (2024-2033)
Table 31. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Colorectal Cancer Diagnostics & Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Colorectal Cancer Diagnostics & Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Colorectal Cancer Diagnostics & Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 63. Biocept Company Details
Table 64. Biocept Business Overview
Table 65. Biocept Colorectal Cancer Diagnostics & Therapeutics Product
Table 66. Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Biocept Recent Developments
Table 68. Cancer Genetics Company Details
Table 69. Cancer Genetics Business Overview
Table 70. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product
Table 71. Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Cancer Genetics Recent Developments
Table 73. Foundation Medicine Company Details
Table 74. Foundation Medicine Business Overview
Table 75. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product
Table 76. Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Foundation Medicine Recent Developments
Table 78. Sysmex Corporation Company Details
Table 79. Sysmex Corporation Business Overview
Table 80. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 81. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Sysmex Corporation Recent Developments
Table 83. Danaher Corporation Company Details
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 86. Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Danaher Corporation Recent Developments
Table 88. Epigenomics Company Details
Table 89. Epigenomics Business Overview
Table 90. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product
Table 91. Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 92. Epigenomics Recent Developments
Table 93. Illumina Company Details
Table 94. Illumina Business Overview
Table 95. Illumina Colorectal Cancer Diagnostics & Therapeutics Product
Table 96. Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 97. Illumina Recent Developments
Table 98. Rosetta Genomics Company Details
Table 99. Rosetta Genomics Business Overview
Table 100. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product
Table 101. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 102. Rosetta Genomics Recent Developments
Table 103. Exact Science Corporation Company Details
Table 104. Exact Science Corporation Business Overview
Table 105. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 106. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 107. Exact Science Corporation Recent Developments
Table 108. Pathway Genomics Corporation Company Details
Table 109. Pathway Genomics Corporation Business Overview
Table 110. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 111. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 112. Pathway Genomics Corporation Recent Developments
Table 113. Taiho Pharma Company Details
Table 114. Taiho Pharma Business Overview
Table 115. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product
Table 116. Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 117. Taiho Pharma Recent Developments
Table 118. Merck KGaA Company Details
Table 119. Merck KGaA Business Overview
Table 120. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product
Table 121. Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 122. Merck KGaA Recent Developments
Table 123. Amgen Company Details
Table 124. Amgen Business Overview
Table 125. Amgen Colorectal Cancer Diagnostics & Therapeutics Product
Table 126. Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 127. Amgen Recent Developments
Table 128. Takeda Company Details
Table 129. Takeda Business Overview
Table 130. Takeda Colorectal Cancer Diagnostics & Therapeutics Product
Table 131. Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 132. Takeda Recent Developments
Table 133. Roche Company Details
Table 134. Roche Business Overview
Table 135. Roche Colorectal Cancer Diagnostics & Therapeutics Product
Table 136. Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 137. Roche Recent Developments
Table 138. Eli Lilly Company Details
Table 139. Eli Lilly Business Overview
Table 140. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product
Table 141. Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 142. Eli Lilly Recent Developments
Table 143. Sanofi Company Details
Table 144. Sanofi Business Overview
Table 145. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product
Table 146. Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 147. Sanofi Recent Developments
Table 148. Regeneron Company Details
Table 149. Regeneron Business Overview
Table 150. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product
Table 151. Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 152. Regeneron Recent Developments
Table 153. Bayer Company Details
Table 154. Bayer Business Overview
Table 155. Bayer Colorectal Cancer Diagnostics & Therapeutics Product
Table 156. Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 157. Bayer Recent Developments
Table 158. Onyx Company Details
Table 159. Onyx Business Overview
Table 160. Onyx Colorectal Cancer Diagnostics & Therapeutics Product
Table 161. Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023) & (US$ Million)
Table 162. Onyx Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Colorectal Cancer Diagnostics Features
Figure 4. Colorectal Cancer Therapeutics Features
Figure 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Region: 2022 VS 2033
Figure 14. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players in 2022
Figure 15. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2022
Figure 17. North America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
Figure 19. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
Figure 20. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
Figure 25. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
Figure 26. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2018-2033)
Figure 27. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
Figure 35. China Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
Figure 36. Asia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
Figure 38. Asia Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
Figure 39. Asia Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2018-2033)
Figure 40. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2018-2033)
Figure 50. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 57. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 58. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 59. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 60. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 61. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 62. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 63. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 64. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 65. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 66. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 67. Merck KGaA Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 68. Amgen Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 69. Takeda Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 70. Roche Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 71. Eli Lilly Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 72. Sanofi Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 73. Regeneron Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 74. Bayer Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 75. Onyx Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed